UCB 62045 - Pharmacology of a novel, dual-function anti-inflammatory agent with histamine type 1 receptor antagonist and 5-lipoxygenase inhibitor activity

被引：4
|
作者：
Selig, WM [1 ]
Bayless, L [1 ]
Libertine, L [1 ]
Eckman, JB [1 ]
Wypij, DM [1 ]
Wels, BF [1 ]
Eckert, M [1 ]
Young, MA [1 ]
Nicolas, JM [1 ]
Scannell, RT [1 ]
Ellis, JL [1 ]
机构：
[1] UCB Res Inc, Pharmacol, Cambridge, MA 02139 USA
来源：
CHEST | 2003年 / 123卷 / 03期
关键词：
D O I：
10.1378/chest.123.3_suppl.371S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：371S / 371S
页数：1
相关论文
共 37 条
  • [1] Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor
    Qian, CG
    Hwang, SB
    Libertine-Garahan, L
    Eckman, JB
    Cai, X
    Scannell, RT
    Yeh, CG
    PHARMACOLOGICAL RESEARCH, 2001, 44 (03) : 213 - 220
  • [2] The effect of a novel, dual function histamine H1 receptor antagonist/5-lipoxygenase enzyme inhibitor on in vivo dermal inflammation and extravasation
    Giannaras, A
    Selig, W
    Ellis, J
    Hullinger, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 506 (03) : 265 - 271
  • [3] The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor
    Li, Liwen
    Ji, Hui
    Sheng, Liang
    Zhang, Yihua
    Lai, Yisheng
    Chen, Xiaorong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 607 (1-3) : 244 - 250
  • [4] 5-lipoxygenase inhibitors with histamine H1 receptor antagonist activity
    Lewis, TA
    Bayless, L
    Eckman, JB
    Ellis, JL
    Grewal, G
    Libertine, L
    Nicolas, JM
    Scannell, RT
    Wels, BF
    Wenberg, K
    Wypij, DM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2265 - 2268
  • [5] Discovery of ucb 35440: A potent and orally active dual acting 5-lipoxygenase inhibitor and H1 receptor antagonist.
    Cai, X
    Arrington, M
    Bayless, L
    Eckman, J
    Eckert, M
    Ene, D
    Ellis, J
    Hussoin, S
    Latham, M
    Lewis, T
    Libertine, L
    Nicolas, JM
    Scannell, R
    Selig, W
    Schwartz, E
    Wels, B
    Wypij, D
    Young, M
    Zou, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U62 - U62
  • [6] Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity
    Hernandez, Maria Rosa
    Tonda, Raul
    Pedreno, Javier
    Salas, Eduardo
    Arderiu, Gemma
    Pino, Marc
    Serradell, Mireia
    Escolar, Gines
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2006, 7 (12) : 859 - 865
  • [7] SC-45662 - A SPECIFIC 5-LIPOXYGENASE INHIBITOR WITH ANTI-ALLERGIC AND ANTI-INFLAMMATORY ACTIVITY
    SMITH, W
    MUELLER, R
    NAKAO, A
    PARTIS, R
    THOMPSON, J
    YANG, DC
    JUNG, G
    PORT, C
    FULLER, G
    FASEB JOURNAL, 1988, 2 (05): : A1109 - A1109
  • [8] Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H1 receptor antagonist properties
    R. T. Scannell
    M. P. Arrington
    L. Bayless
    X. Cai
    J. B. Eckman
    M. Eckert
    D. G. Ene
    J. L. Ellis
    S. Hussoin
    G. M. Latham
    T. A. Lewis
    L. Libertine
    J. Nicolas
    W. M. Selig
    C. E. Schwartz
    B. F. Wels
    D. M. Wypij
    M. A. Young
    D. Zou
    Inflammation Research, 2004, 53 : S33 - S34
  • [9] Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H1 receptor antagonist properties
    Scannell, RT
    Arrington, MP
    Bayless, L
    Cai, X
    Eckman, JB
    Eckert, M
    Ene, DG
    Ellis, JL
    Hussoin, S
    Latham, GM
    Lewis, TA
    Libertine, L
    Nicolas, J
    Selig, WM
    Schwartz, CE
    Wels, BF
    Wypij, DM
    Young, MA
    Zou, D
    INFLAMMATION RESEARCH, 2004, 53 (Suppl 1) : S33 - S34
  • [10] Is licofelone, a dual inhibitor of cyclo-oxygenase and 5-lipoxygenase, a promising alternative in anti-inflammatory therapy?
    Bannwarth, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 (01) : 125 - 130
1234